Costantino P D, Friedman C D, Pelzer H J
Department of Otolaryngology, Head and Neck Surgery, Northwestern University Medical School, Chicago, IL 60611.
Arch Otolaryngol Head Neck Surg. 1989 Mar;115(3):380-3. doi: 10.1001/archotol.1989.01860270122026.
Neurofibromatosis type II (NF-II) has been traditionally referred to as "acoustic" neurofibromatosis and is not known to be genetically distinct from classic von Recklinghausen's disease (NF-I). Neurofibromatosis type II is due to a lesion on chromosome 22q, while von Recklinghausen's neurofibromatosis is from a defect on chromosome 17. The approximate incidence of NF-II is one in 50,000, with bilateral acoustic neuromas occurring in over 90% of those with the abnormal gene. We studied a 17-year-old boy with NF-II who presented with bilateral acoustic neuromas and concomitant primary nasopharyngeal meningioma. Less than 30 nasopharyngeal meningiomas have been documented, and the presence of both tumor types in the same individual is unique in the literature.
II型神经纤维瘤病(NF-II)传统上被称为“听神经”神经纤维瘤病,目前尚不清楚其在基因上与经典的冯雷克林霍增氏病(NF-I)有何不同。II型神经纤维瘤病是由22号染色体上的病变引起的,而冯雷克林霍增氏神经纤维瘤病则源于17号染色体上的缺陷。NF-II的发病率约为五万分之一,超过90%携带异常基因的患者会出现双侧听神经瘤。我们研究了一名患有NF-II的17岁男孩,他患有双侧听神经瘤并伴有原发性鼻咽部脑膜瘤。文献记载的鼻咽部脑膜瘤病例不到30例,同一个体同时出现这两种肿瘤类型在文献中是独一无二的。